Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su): A phase-I, open-label study in Japanese adults

An adjuvanted recombinant subunit candidate vaccine (HZ/su) containing varicella zoster virus envelope glycoprotein E was developed for the prevention of herpes zoster and its complications. This study evaluated safety and reactogenicity of HZ/su in an ethnic Japanese population. This was a phase I,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lal, Himal, Zahaf, Toufik, Heineman, Thomas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890214/
https://www.ncbi.nlm.nih.gov/pubmed/23584252
http://dx.doi.org/10.4161/hv.24269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890214/
https://www.ncbi.nlm.nih.gov/pubmed/23584252
http://dx.doi.org/10.4161/hv.24269

Ejemplares similares